U.S. Patient Monitoring Market

U.S. Patient Monitoring Market Size (2024 to 2029)

The patient monitoring market size in the United States was worth USD 6.67 Billion in 2024 and is projected to rise at a robust CAGR during the forecast period.

Patient monitoring system involves continuous and repeated observations for patients, monitoring patient's physiological functions, quality checking for life support equipment. This system also includes monitoring vital tasks for patients and provides easy access to patients in their location with portable devices and parameters. 

The United States is considered a technologically developed country, and healthcare and infrastructure are top-notch for its economy. Healthcare workers, frontliners, physicians, and nursing staff are very active and massive. It adds to the benefit of the patient monitoring market. By this means of methods, a person can get treatment at their location and monitor medical staff. Government funding for the patient monitoring market helps this market size to grow. Along with the government, non-governmental organizations also show up in funding for this market. An increase in adaption and demand for the mobile health market increases the patient monitoring market through the ease of communication, safety, and measures. 

The senior population with little knowledge of technology and devices does not use any technology mode to approach healthcare services on an online platform. For elderly patients, patient marketing services on the online platform are not recommended for safety concerns. There are difficulties associated with difficult cases and weak patients. It is not possible to insert monitoring instruments such as pulmonary devices. Few factors may also increase the mortality rate. For only a specific set of conditions, patient monitoring services are recommended. The stringent rules and regulations for the approvals hampered market growth, and this market's organizations made this stricter. 

COVID-19 Impact on this market

The recent outbreak of COVID-19 has turned down plates for the healthcare industry and impacted patient monitoring devices. An increase in the number of COVID-19 cases has resulted in an evolution in the market. There is a severe shortage of medical supplies, and it has a significant impact on the market. It has been hard for doctors, frontline workers, healthcare staff to take care of patients following the lockdown and social distancing norms. Due to travel ban issues, there was a severe shortage of staff when needed in emergence. Also, for patients from remote areas, there have been no facilities as such to approach or to commute to clinics as well.  

Country-Level Analysis

The US patient monitoring market is continuing to dominate the market and is presently leading the North American region. Increased adaption of mobile patient monitoring and increase usage of mobile phones contribute to market growth. Private and public organizations' investments and funds across this region developed market growth as well. Government investments for research and developmental activities also have a top benefit for this market in the United States. 

Companies like Covidien, Abbott Laboratories, Drager, Medical GmbH, GE Healthcare, Johnson & Johnson Inc., Masimo Corporation, Mindray Medical, Mortara Instrument Inc., Natus, Nihon Kohden, Nonin Medical, Omron Healthcare, Philips Healthcare, Roche Diagnostics Limited, and Welch Allyn are playing a significant role in the U.S. patient monitoring market.